Effect of iron overload on renal functions and oxidative stress in beta thalassemia patients

References

1. ↵
   1. Ali BA,
   2. Mahmoud AM

   (2014) Frequency of glomerular dysfunction in children with beta thalassaemia major. Sultan Qaboos Univ Med J 14:88–94.

   OpenUrl
2. ↵
   1. Raghupathy R,
   2. Manwani D,
   3. Little JA

   (2010) Iron overload in sickle cell disease. Adv Hematol 2010:272940.

   OpenUrlCrossRefPubMed
3. ↵
   1. Kohgo Y,
   2. Ikuta K,
   3. Ohtake T,
   4. Torimoto Y,
   5. Kato J

   (2008) Body iron metabolism and pathophysiology of iron overload. Int J Hematol 88:7–15.

   OpenUrlCrossRefPubMed
4. ↵
   1. Pavlova LE,
   2. Savov VM,
   3. Petkov HG,
   4. Charova IP

   (2007) Oxidative stress in patients with beta-thalassemia major. Prilozi 28:145–154.

   OpenUrlPubMed
5. ↵
   1. Malik A,
   2. Qureshi MS,
   3. Manan A,
   4. Saleem S,
   5. Munir M,
   6. Fatima A,
   7. et al.

   (2013) assessment of oxidative stress in hepatitis C patients receiving interferon therapy. Pakistan Journal of Medicine and Dentistry 2:10–15.

   OpenUrl
6. ↵
   1. Shazia Q,
   2. Mohammad ZH,
   3. Rahman T,
   4. Shekhar HU

   (2012) Correlation of oxidative stress with serum trace element levels and antioxidant enzyme status in beta thalassemia major patients: A review of the literature. Anemia, 1–7.
7. ↵
   1. Walter PB,
   2. Fung E,
   3. Killilea DW,
   4. Jiang Q,
   5. Hudes M,
   6. Madden J

   (2006) Oxidative stress and inflammation in iron-overloaded patients with beta thalassemia or sickle cell disease. Br J Haematol 135:254–263.

   OpenUrlCrossRefPubMed
8. ↵
   1. Kremastinos DT,
   2. Farmakis D

   (2011) Iron overload cardiomyopathy in clinical practice. Circulation 124:2253–2263.

   OpenUrlFREE Full Text
9. ↵
   1. Eghbali A,
   2. Taherahmadi H,
   3. Shahbazi M,
   4. Bagheri B,
   5. Ebrahimi L

   (2014) Association between serum ferritin level, cardiac and hepatic T2-star MRI in patients with major b-thalassemia. Iran J Ped Hematol Oncol 4:17–21.

   OpenUrl
10. ↵
    1. Borgna-Pignatti C,
    2. Vergine G,
    3. Lombardo T,
    4. Cappellini MD,
    5. Cianciulli P,
    6. et al.

    (2004) Hepatocellular carcinoma in the thalassemia syndromes. Br J Haematol 124:114–117.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Rasool M,
    2. Rashid S,
    3. Arooj M,
    4. Ansari SA,
    5. Khan KM,
    6. Malik A,
    7. et al.

    (2014) New possibilities in hepatocellular carcinoma treatment. Anticancer Res 34:1563–1571.

    OpenUrlAbstract/FREE Full Text
12. ↵
    1. Mary AK,
    2. Jonathan AS,
    3. Lan GC,
    4. Suzy VT,
    5. Frank MT

    (2009) Ferritin for the clinician. Blood Rev 23:195–104.

    OpenUrl
13. ↵
    1. Chakraborty I,
    2. Mitra S,
    3. Gachhui R,
    4. Kar M

    (2010) Non-haem Iron-mediated Oxidative Stress in Haemoglobin E Beta-thalassaemia. Ann Acad Med Singapore 39:13–16.

    OpenUrlPubMed
14. ↵
    1. Laksmitawati DR,
    2. Handayani S,
    3. Udyaningsih-Freisleben SK,
    4. Kurniati V,
    5. Adhiyanto C,
    6. Hidayat J

    (2003) Iron status and oxidative stress in beta-thalassemia patients in Jakarta. Biofactors 19:53–62.

    OpenUrlPubMedWeb of Science
15. 1. Ohkawa H,
    2. Ohishi N,
    3. Yagi K

    (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358.

    OpenUrlCrossRefPubMedWeb of Science